Lessons learned from the mouse model of short-chain acyl-CoA dehydrogenase deficiency
Related Experiment Video
Updated: Oct 17, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
P A Wood1, C L Kelly-Kurtz, M E Hinsdale
1Department of Comparative Medicine, School of Medicine, University of Alabama at Birmingham 35294-0019, USA.
Abstract:
The SCAD deficient mouse model has been useful to investigate mechanisms of deficient fatty acid oxidation disease in human patients. This mouse model has been thoroughly characterized and is readily available from the Jackson Laboratory. Using the new technologies of gene-knockout mouse modeling, we envisage developing additional members of the acyl-CoA dehydrogenase family of enzyme deficiencies in mice and furthering our understanding of fatty acid metabolism in health and disease.

